Literature DB >> 7679730

Tachykinins potentiate N-methyl-D-aspartate responses in acutely isolated neurons from the dorsal horn.

K I Rusin1, D Bleakman, P S Chard, M Randic, R J Miller.   

Abstract

Substance P and neurokinin A both potentiated N-methyl-D-aspartate (NMDA)-induced currents recorded in acutely isolated neurons from the dorsal horn of the rat. To elucidate the mechanism underlying this phenomenon, we measured the effects of tachykinins and glutamate receptor agonists on [Ca2+]i in these cells. Substance P, but not neurokinin A, increased [Ca2+]i in a subpopulation of neurons. The increase in [Ca2+]i was found to be due to Ca2+ influx through voltage-sensitive Ca2+ channels. Substance P and neurokinin A also potentiated the increase in [Ca2+]i produced by NMDA, but not by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, kainate, or 50 mM K+. Phorbol esters enhanced the effects of NMDA and staurosporine inhibited the potentiation of NMDA effects by tachykinins. It is concluded that activation of protein kinase C may mediate the enhancement of NMDA effects by tachykinins in these cells. However, the effects of tachykinins on [Ca2+]i can be dissociated from their effects on NMDA receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679730     DOI: 10.1111/j.1471-4159.1993.tb03242.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

1.  Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus.

Authors:  H Liu; A M Mazarati; H Katsumori; R Sankar; C G Wasterlain
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Activation of group I mGlu receptors contributes to facilitation of NMDA receptor membrane current in spinal dorsal horn neurons after hind paw inflammation in rats.

Authors:  Kun Yang; Keita Takeuchi; Feng Wei; Ronald Dubner; Ke Ren
Journal:  Eur J Pharmacol       Date:  2011-09-21       Impact factor: 4.432

3.  Substance P enhances excitatory synaptic transmission on spinally projecting neurons in the rostral ventromedial medulla after inflammatory injury.

Authors:  Liang Zhang; Donna L Hammond
Journal:  J Neurophysiol       Date:  2009-06-03       Impact factor: 2.714

4.  Enhanced phosphorylation of NMDA receptor 1 subunits in spinal cord dorsal horn and spinothalamic tract neurons after intradermal injection of capsaicin in rats.

Authors:  X Zou; Q Lin; W D Willis
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

5.  Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene.

Authors:  A Zimmer; A M Zimmer; J Baffi; T Usdin; K Reynolds; M König; M Palkovits; E Mezey
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

6.  Central versus peripheral site of action of the tachykinin NK1-antagonist RP 67580 in inhibiting chemonociception.

Authors:  U Holzer-Petsche; T Rordorf-Nikolić
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

7.  Protein kinase A-dependent enhanced NMDA receptor function in pain-related synaptic plasticity in rat amygdala neurones.

Authors:  Gary C Bird; L Leanne Lash; Jeong S Han; Xiaoju Zou; William D Willis; Volker Neugebauer
Journal:  J Physiol       Date:  2005-03-10       Impact factor: 5.182

8.  Modulation of hypoglossal motoneuron excitability by NK1 receptor activation in neonatal mice in vitro.

Authors:  K Yasuda; D M Robinson; S R Selvaratnam; C W Walsh; A J McMorland; G D Funk
Journal:  J Physiol       Date:  2001-07-15       Impact factor: 5.182

9.  An isobolographic analysis of the effects of N-methyl-D-aspartate and NK1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat.

Authors:  K Ren; M J Iadarola; R Dubner
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

10.  Modulation of excitatory amino acid responses by tachykinins and selective tachykinin receptor agonists in the rat spinal cord.

Authors:  M J Cumberbatch; B A Chizh; P M Headley
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.